Inhibition of cyclo-oxigenase-2 activity does not abolish the anabolic effect of prostaglandin E2 in vivo or in vitro

Journal of Endocrinology

Volumn 174, Issue 1, 2002, Pages 127-135

  Weinreb, M ^a   Kelner, A ^a   Keila, S ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANABOLIC AGENT; CARRAGEENAN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIMETHYL SULFOXIDE; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MASS; BONE MINERALIZATION; BONE TISSUE; CANCELLOUS BONE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORTICAL BONE; DOSE RESPONSE; ENZYME INHIBITION; FEMUR; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; NONHUMAN; ORGAN CULTURE; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STROMA CELL;

ANIMALS; BONE AND BONES; BONE REMODELING; CYCLOOXYGENASE 2; DINOPROSTONE; ISOENZYMES; MALE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER;

EID: 0036319489     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1740127     Document Type: Article

References (48)

1. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes
2. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
3. 2 receptor subtype
4. Renal abnormalities and an altered inflammatory response in mice lacking COX-II
5. Cloning and characterization of a growth-factor inducible cyclooxigenase gene from rat intestinal epithelial cells
6. Inducible COX-2 mediates the induction of bone formation by mechanical loading in vivo
7. Anti-inflammatory activity and pharmacokinetic profile of a new parenteral formulation of nimesulide
8. Prostaglandin synthase 2
9. 2 upregulates COX-2 expression in LPS-stimulated RAW 264.7 macrophages
10. Effects of selective COX-2 inhibitors on alkaline secretory and mucosal ulcerogenic responses in rat duodenum
11. ER-34122, a novel dual 5-lipoxigenase/COX inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model
12. In vivo anabolic actions of prostaglandins in bone
13. 2
14. 2 prevents disuse-induced cortical bone loss
15. 2 in cultured neonatal mouse calvariae
16. Bone marrow from mechanically unloaded rat bones expresses reduced osteogenic capacity in vitro
17. 2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro
18. Cloning and expression of rat prostaglandin endoperoxide synthase (COX-2) cDNA
19. Pulsating fluid flow stimulates prostaglandin release and inducible PGHS mRNA expression in primary mouse bone cells
20. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
21. 2 stimulated hypercalcemia and bone loss in mice in vivo
22. 2
23. 2 regulation of cyclooxigenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors
24. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats
25. The selective prostaglandin endoperoxide synthase-2 inhibitor, NS-398, reduces prostaglandin production and ovulation in vivo and in vitro in the rat
26. 2 receptor subtypes in M-1 mouse CCD cells
27. The role of prostaglandins in bone in vivo. A review
28. Effects of COX-2 gene disruption on osteoblastic function
29. Bone histomorphometry: Standardization of nomenclature, symbols and units
30. Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells
31. Autoregulation of inducible prostaglandin G/H synthase in osteoblastic cells by prostaglandins
32. Prostaglandins and bone metabolism
33. Prostaglandins: Mechanisms of action and regulation of production in bone
34. 2 on bone: Induction of a transition from non-adherent to adherent osteoblast precursors
35. 2-mediated mechanism
36. Role of COX-2 in the healing of gastric ulcers in rats
37. Prostaglandin endoperoxide synthases: Structure and catalysis
38. Prostaglandin endoperoxide synthases-1 and -2
39. 1 subtype of PGE receptor in mouse osteoblastic MC3T3-E1 cells
40. 2 in long bones and calvariae of young rats
41. Studies on the induction of cyclooxigenase isoenzymes by various prostaglandins in mouse osteoblastic cell line with reference to signal transduction pathways
42. 2 in rapidly growing rats: Depressed longitudinal and radial growth and increased metaphyseal hard tissue mass
43. Transcriptional regulation of the COX-2 gene by diverse ligands in murine osteoblasts
44. Immobilization-related bone loss in the rat is increased by calcium deficiency
45. Systemic administration of an anabolic dose of prostaglandin E2 induces early-response genes in rat bones
46. 2 in young rats increases the osteogenic capacity of bone marrow
47. 4 receptor subtype
48. 2 in osteoblastic cell lines and adult rat bone tissue